State Street Corp Verrica Pharmaceuticals Inc. Put Options Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VRCA
# of Institutions
55Shares Held
16.5MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY8.88MShares$70.6 Million1.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$17.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.13MShares$8.98 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny907KShares$7.21 Million0.0% of portfolio
-
Sovran Advisors, LLC San Diego, CA750KShares$5.97 Million0.07% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $327M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...